Multidisciplinary Treatment Sequencing and Coordination

Author(s):

Kevin Kalinsky, MD, MS,Virginia Kaklamani, MD

Panelists discuss their approach to sequencing surgery, radiation, and systemic therapies for early-stage breast cancer patients, emphasizing the guiding principles of treatment sequencing and how individual patient factors influence decisions; they also highlight the importance of multidisciplinary coordination, identifying key specialists, ensuring alignment on diagnosis, risk assessment, and treatment goals, and the critical role of including the patient in these discussions.

EP: 1.Introduction and HR+/HER2– eBC Overview

EP: 2.Approaches to eBC Diagnosis and Risk Stratification

EP: 3.CDK4/6 Inhibitors Treatment Options in the eBC Setting

EP: 4.Clinical Trial Considerations for eBC Treatment Selection

EP: 5.Clinical Decision-Making for a Patient With eBC: Scenario and Strategies

EP: 6.Managing CDK4/6 Inhibitor Toxicities and Encouraging Adherence

Now Viewing

EP: 7.Multidisciplinary Treatment Sequencing and Coordination

Video content above is prompted by the following:

Could you explain your approach to sequencing surgery, radiation, and systemic therapies for early-stage patients?
1. What principles guide your treatment sequencing recommendations
2. To what extent does sequencing vary based on individual patient factors?
Dr Kalinsky to Dr Kaklamani: What multidisciplinary coordination is vital to optimizing care for patients in this setting?
1. Which specialists should be involved, and what is their role on the treatment team?
2. How do you ensure the multidisciplinary team is aligned on diagnosis, risk assessment, and treatment goals for each patient?
3. What is the importance of including the patient in these treatment goal discussions?